trending Market Intelligence /marketintelligence/en/news-insights/trending/A_ZJfZdq2rxrfEUNxD4jTw2 content esgSubNav
In This List

US FDA clears ZELTIQ's fat-removal treatment for upper arms

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


US FDA clears ZELTIQ's fat-removal treatment for upper arms

The U.S. FDA cleared ZELTIQ Aesthetics Inc.'s CoolSculpting, a noninvasive fat-removal technology for upper arms.

The company will also launch the CoolAdvantage Petite applicator for the CoolSculpting system to optimize the performance of CoolSculpting in the upper arms, with full commercial release targeted for the middle of 2017.